Gene · 1048
Papers3,868
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,868
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-omics in nasal epithelium reveals three axes of dysregulation for asthma risk in the African Diaspora populations. | Nat Commun | 2024 | 38806494 | PubTator, text mining | PubMed |
| Camelid-derived Tcell engagers harnessing human γδ T cells as promising antitumor immunotherapeutic agents. | Eur J Immunol | 2024 | 38804118 | PubTator, text mining | PubMed |
| CEACAM5-Targeted Immuno-PET in Androgen Receptor-Negative Prostate Cancer. | J Nucl Med | 2024 | 38782457 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates as Novel Therapeutic Agents for Non-Small Cell Lung Carcinoma with or without Alterations in Oncogenic Drivers. | BioDrugs | 2024 | 38767823 | PubTator, text mining | PubMed |
| Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates. | NPJ Precis Oncol | 2024 | 38760413 | PubTator, text mining | PubMed |
| [The influence of knocking down the expression of low-density lipoprotein receptor associated proteins on the vascular abnormalities in hepatocellular carcinoma and its mechanisms]. | Zhonghua Zhong Liu Za Zhi | 2024 | 38742353 | PubTator, text mining | PubMed |
| Expression of Potential Antibody-Drug Conjugate Targets in Cervical Cancer. | Cancers (Basel) | 2024 | 38730739 | PubTator, text mining | PubMed |
| Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody. | Front Immunol | 2024 | 38720892 | PubTator, text mining | PubMed |
| LGR6 is a prognostic biomarker for less differentiated tumors in lymph nodes of colon cancer patients. | Front Oncol | 2024 | 38715790 | PubTator, text mining | PubMed |
| A Frequent Diagnostic Pitfall: Dermatological Clinical Features and Pathological Results in Diagnosing Pagetoid Squamous Cell Carcinoma in situ (Case Series). | Clin Cosmet Investig Dermatol | 2024 | 38699407 | PubTator, text mining | PubMed |
| The effects of inhaled corticosteroids on healthy airways. | Allergy | 2024 | 38686450 | PubTator, text mining | PubMed |
| SARS-Cov-2 spike induces intestinal barrier dysfunction through the interaction between CEACAM5 and Galectin-9. | Front Immunol | 2024 | 38686388 | PubTator, text mining | PubMed |
| [Expression and prognostic significance of KAP1 gene in malignant pleural mesothelioma]. | Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi | 2024 | 38677988 | PubTator, text mining | PubMed |
| Single-cell analysis revealed a potential role of T-cell exhaustion in colorectal cancer with liver metastasis. | J Cell Mol Med | 2024 | 38647235 | PubTator, text mining | PubMed |
| Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted Therapies. | bioRxiv | 2024 | 38645034 | PubTator, text mining | PubMed |
| New therapeutic target molecules for gastric and gastroesophageal junction cancer. | Int J Clin Oncol | 2024 | 38630383 | PubTator, text mining | PubMed |
| N-glycoproteomic analyses of human intestinal enteroids, varying in histo-blood group geno- and phenotypes, reveal a wide repertoire of fucosylated glycoproteins. | Glycobiology | 2024 | 38590172 | PubTator, text mining | PubMed |
| miR-122-IGF-1R signaling allied through the dysregulated lncRNA MALAT-1 expression in gastric carcinoma. | Toxicol Rep | 2024 | 38544957 | PubTator, text mining | PubMed |
| Phenotypic screen of sixty-eight colorectal cancer cell lines identifies CEACAM6 and CEACAM5 as markers of acid resistance. | Proc Natl Acad Sci U S A | 2024 | 38502695 | PubTator, text mining | PubMed |
| Characteristics of Carcinoembryonic Antigen-Related Cell Adhesion Molecules and Their Relationship to Cancer. | Mol Cancer Ther | 2024 | 38490257 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1048/papers?page=11